Psyence BiomedicalPBM
13F holders, Q2 2026 (June 30)9holders +7
7new positions
0sold out
1famous investor
$3.36avg. 13F price*
At the end of Q2 2026, 9 institutions reported holding Psyence Biomedical Ltd. (PBM) in their 13F filings, up 7 from Q1 2026. 7 opened new positions and 0 sold out. The largest holders were Parallel Advisors, LLC ($575K), AdvisorShares Investments LLC ($374K) and Morgan Stanley ($116K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F407
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $665K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 217,301 shares bought, net +217,301 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Parallel Advisors, LLC | 0.01% | No change | 151,250 | $575K |
| AdvisorShares Investments LLC | 0.05% | New | 122,184 | $374K |
| Morgan Stanley | 0.00% | New | 37,804 | $116K |
| Jane Street Group, LLC | 0.00% | New | 30,431 | $93K |
| XTX Topco Ltd | 0.00% | New | 15,094 | $46K |
| Citadel Advisors | 0.00% | New | 11,693 | $36K |
| Stonehage Fleming Financial Services Holdings Ltd | 0.00% | No change | 89 | $272 |
| UBS Group AG | 0.00% | New | 60 | $184 |
| Caitlin John, LLC | 0.00% | New | 35 | $107 |
"% of holder's portfolio" is PBM's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.